Midway through trading Monday, the Dow traded up 0.27 percent to 16,405.23 while the NASDAQ declined 0.80 percent to 4,042.85. The S&P also fell, dropping 0.05 percent to 1,862.56.
Leading and Lagging Sectors
Telecommunications services shares gained around 0.83 percent in the US market on Monday. Top gainers in the sector included China Telecom Corp. (NYSE: CHA), Turkcell Iletisim Hizmetleri AS (NYSE: TKC), and China Unicom (Hong Kong) Limited (NYSE: CHU). In trading on Monday, basic materials shares were relative laggards, down on the day by about 0.75 percent.
Top 5 European Companies For 2015: Henry Schein Inc. (HSIC)
Henry Schein, Inc. distributes healthcare products and services primarily to office-based healthcare practitioners. It operates in two segments, Healthcare Distribution and Technology. The Healthcare Distribution segment offers consumable dental products, dental laboratory products, and small equipment, including X-ray products, infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, and abrasives; and large dental equipment comprising dental chairs, delivery units and lights, X-ray equipment, equipment repair, and high-tech equipment. It also provides medical products, including branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins; and animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment. The Technology segment offers softwar e and related products, and value-added products that primarily include practice management software systems for dental and medical practitioners, and animal health clinics. Its services also consist of financial services and continuing education services for practitioners. Henry Schein, Inc. primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government and other institutions. It operates in the United States, Australia, Austria, Belgium, Canada, China, the Czech Republic, France, Germany, Hong Kong, Ireland, Israel, Italy, Luxembourg, the Netherlands, New Zealand, Portugal, Slovakia, Spain, Switzerland, and the United Kingdom. The company was founded in 1932 and is headquartered in Melville, New York.
Advisors' Opinion:- [By John Bonnanzio]
The fund�� top holdings are Telsa, Henry Schein (HSIC), United Rentals (URI), Gartner (IT) and Kansas City Southern (KSU).
The fund also has some exposure to pricey biotech. Even so, this is hardly a shoot-the-lights-out growth fund as volatility is below all his mid-cap peers. To that end, this trade actually tempers risk while increasing growth exposure.
Best Services Companies To Invest In Right Now: Healthcare Realty Trust Inc (HR)
Healthcare Realty Trust Incorporated (Healthcare Realty), incorporated in 1993, is a self-managed and self-administered real estate investment trust (REIT) that owns, acquires, manages, finances and develops income-producing real estate properties associated with the delivery of outpatient healthcare services throughout the United States. During the year ended December 31, 2011, the Company disposed of five real estate properties. In January 2012, the Company purchased a 58,295 square foot medical office building in South Dakota. In February 2012, the Company purchased a 23,312 square foot medical office building in North Carolina. The property is 100% leased by two tenants. In January 2012, the Company disposed of two medical office buildings located in Texas. In January 2012, the Company disposed of a medical office building located in Florida. In January 2012, an inpatient facility under construction in South Dakota that was being funded by the Company through a mortgage note was sold. On March 15, 2011, the Company acquired Lakewood MOB, LLC. On March 31, 2011, it acquired HR Ladco Holdings, LLC. Effective October 22, 2013, Healthcare Realty Trust Inc acquired First Hill Medical Building.
As of December 31, 2011, the Company provided property management services for 150 healthcare-related properties nationwide, totaling approximately 10.3 million square feet. The Company�� portfolio of properties is focused on medical office and outpatient sector of the healthcare industry and is diversified by geographic location, tenant and facility type.
Advisors' Opinion:- [By Dividends4Life]
Memberships and Peers: UHT is, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: Hersha Hospitality Trust (HT) with a 4.4% yield, Healthcare Realty Trust Incorporated (HR) with a 5.2% yield and LTC Properties Inc. (LTC) with a 5.4% yield.
Best Services Companies To Invest In Right Now: Infinity Pharmaceuticals Inc.(INFI)
Infinity Pharmaceuticals, Inc. engages in the discovery and development of medicines for difficult-to-treat diseases. The company?s lead product candidates include saridegib (IPI-926), an oral molecule with the potential to treat a range of cancers by disrupting malignant activation of the Hedgehog pathway; and Retaspimycin HCl (IPI-504), a heat shock protein 90 (Hsp90) inhibitor. Its Saridegib is in a Phase II clinical trial for the treatment of metastatic or inoperable chondrosarcoma and a Phase II exploratory trial in patients with myelofibrosis. The company?s Retaspimycin HCl is in a Phase II trial in combination with docetaxel to treat patients with non-small cell lung cancer (NSCLC); and in a Phase Ib/II trial in combination with everolimus, known as Afinitor, in approximately 45 NSCLC patients with a KRAS mutation. Its pipeline also includes IPI-145, an inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) in Phase I development to treat in flammation and hematologic malignancies. Infinity Pharmaceuticals has a strategic alliance with Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Limited to develop and commercialize pharmaceutical products; and a development and license agreement with Millennium to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K, including IPI-145. Purdue Pharmaceutical Products is planning to conduct Phase II studies of IPI-940 in pain. The company is headquartered in Cambridge, Massachusetts.
Advisors' Opinion:- [By Keith Speights]
No win for the spin
Another biotech, Infinity Pharmaceuticals (NASDAQ: INFI ) , also announced clinical results this week. The company's press release trumpeted "encouraging" findings for its experimental leukemia drug. Mr. Market didn't appear to buy the spin. Infinity shares tanked nearly 33% for the week. - [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
Best Services Companies To Invest In Right Now: Home Inns & Hotels Management Inc.(HMIN)
Home Inns & Hotels Management Inc. develops, leases, operates, franchises, and manages a chain of economy hotels in the People?s Republic of China. The company operates its hotels under the Home Inn brand name. As of April 28, 2011, it had approximately 800 Home Inns in operation and 1,000 Home Inns sealed in franchise agreements. The company was incorporated in 2001 and is headquartered in Shanghai, the People?s Republic of China.
Advisors' Opinion:- [By Jim Jubak]
We��e been down this road with Home Inns and Hotels Management (HMIN) before. Which doesn�� make it any less scary.
The stock is down 22.2% in the last ten days��espite solid��ut certainly not spectacular��esults for the fourth quarter, reported on March 12.
- [By Monica Gerson]
Home Inns & Hotels Management (NASDAQ: HMIN) is estimated to post its Q4 earnings at $2.18 per share on revenue of $1.54 billion.
Qiwi plc (NASDAQ: QIWI) is expected to report its Q4 earnings at $0.28 per share on revenue of $50.00 million.
No comments:
Post a Comment